No Data
Form 144(Amend) | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its co
Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common
GeneDx Holdings Is Maintained at Buy by BTIG
GeneDx Holdings Is Maintained at Buy by BTIG
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $35
BTIG analyst Mark Massaro maintains $GeneDx Holdings(WGS.US)$ with a buy rating, and adjusts the target price from $19 to $35.According to TipRanks data, the analyst has a success rate of 29.1% and a
GeneDx Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 28.44% BTIG $19 → $35 Maintains Buy 04/30/2024 -11.93% TD Cowen $14 → $24 Maintains Buy 04/30/2
Express News | GeneDx Holdings Corp : Btig Raises Target Price to $35 From $19
Mars MoooOP :![](https://emoticon.futunn.com/rich_daily_life/O_33.png)